丹娜生物 — Investor Relations & Filings

Dynamiker Biotechnology specializes in the research, development, and manufacturing of in vitro diagnostic (IVD) solutions, focusing on the early detection and monitoring of invasive fungal diseases (IFD). The company offers a comprehensive diagnostic portfolio targeting pathogens such as Aspergillus, Candida, Cryptococcus, and Pneumocystis jirovecii. Its core product lines include (1-3)-β-D-glucan (G test), Galactomannan (GM test), and Cryptococcal Antigen (CrAg) assays, utilizing methodologies like ELISA, lateral flow, and molecular diagnostics. These products are designed to provide rapid, sensitive, and specific results for clinical decision-making. Dynamiker maintains international quality standards and certifications, supporting its commitment to improving diagnostic accuracy and patient management in global healthcare settings.